CD8+ lymphocytes in pregnancy and HIV infection: Characterization of CD8+ subpopulations and CD8+ noncytotoxic antiviral activity

AIDS Research and Human Retroviruses

Volumn 15, Issue 7, 1999, Pages 665-670

  Rich, Kenneth C ^a   Siegel, Joan N ^b   Jennings, Cheryl ^b   Rydman, Robert J ^a   Landay, Alan L ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; PREGNANCY; PRIORITY JOURNAL; VIRUS REPLICATION;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTE SUBSETS; VIRUS REPLICATION;

EID: 0033135104     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310962     Document Type: Article

References (30)

1. Giorgi JV, Ho H-N, Hirji K, Chou C-C, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J, and Phair JP: CD8+ lymphocyte activation at human immunodeficiency viras type 1 seroconversion: Development of HLA-DR+ CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis 1994;170:775-781.
2. Levy JA, Mackewicz CE, and Barker E: Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996;17:217-224.
3. Barker E, Mackewicz CE, and Levy JA: Effects of Th1 and Th2 cytokines on CD8+ cell response against human immunodeficiency virus: Implications for long-term survival. Proc Natl Acad Sci USA 1995;92:11135-11139.
4. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1814.
5. Kinter AL, Bende SM, Hardy EC, Jackson R, and Fauci AS: Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. Proc Natl Acad Sci USA 1995;92:1085-1089.
6. Sridama V, Pacini F, Yang S-L, Moawad A, Reilly M, and De-Groot LJ: Decreased levels of helper T cells. A possible cause of immunodeficiency in pregnancy. N Engl J Med 1982;307:352-356.
7. Tallon DF, Corcoran DJD, O'Dwyer EM, and Greally JF: Circulating lymphocyte subpopulations in pregnancy: A longitudinal study. J Immunol 1984;132:1784-1787.
8. Maclean MA, Wilson R, Thomson JA, Krishnamurthy S, and Walker JJ: Changes in immunologic parameters in normal pregnancy and spontaneous abortion. Am J Obstet Gynecol 1991; 165:890-895.
9. Fiddes TM, O'Reilly DB, Cetrulo CI, Miller W, Rudders R, Osband M, and Rocklin RE: Phenotypic and functional evaluation of suppressor cells in normal pregnancy and in chronic aborters. Cell Immunol 1986;92:407-418.
10. Miotti PG, Liomba G, Dallabetta GA, Hoover DR, Chiphaugwi JD, and Saah AJ: T lymphocyte subsets during and after pregnancy: Analysis in human immunodeficiency virus type-1 infected and uninfected Malawian mothers. J Infect Dis 1992;165:1116-1119.
11. Temmerman M, Nagelkerke N, Bwayo J, Chombra EN, Ndmya-Achola J, and Piot P: HIV and immunologic changes during pregnancy: A comparison between HIV-1 seropositive and HIV-1 seronegative women in Nairobi, Kenya. AIDS 1995;9:1057-1060.
12. Mikyas Y, Aziz N, Harawa N, Gorre M, Neagos N, Nogueira M, Wafer D, Dillon M, Boyer PJ, Bryson YJ, and Plaeger S: Immunologic activation during pregnancy: Serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol 1997;33: 157-170.
13. Rich KC, Siegel JN, Jennings C, Rydman RJ, and Landay AL: CD4+ lymphocytes in perinatal HIV infection: Evidence for pregnancy induced immune depression in uninfected and HIV infected women. J Infect Dis 1995;172:1221-1227.
14. Tuomala RE, Kalish LA, Zorilla C, Fox H, Shearer W, Landay A, Vermund SH, Landesman S, and Burns D for the Women and Infants Transmission Study: Changes in total, CD4+ and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. Obstet Gynecol 1997;89: 967-974.
15. Brettle RP, Raab GM, Ross A, Fielding KL, Gore SM, and Bird AG: HIV infection in women: Immunological markers and the influence of pregnancy. AIDS 1995;9:1177-1184.
16. Biggar RJ, Pahwa S, Minkoff H, Mendes H, Willoughby A, Landesman S, and Goedert JJ: Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol 1989;161:1239-1244.
17. Burns DN, Nourjah P, Minkoff H, Korelitz J, Biggar RJ, Landesman S, Rubinstein A, Wright D, and Nugent RP: Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. Am J Obstet Gynecol 1996;174:1461-1468.
18. Landay AL, Mackewicz CD, and Levy JA: An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 1993; 69:106-116.
19. Watret KC, Whitelaw JA, Froebel KSA, and Bird AG: Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity. Clin Exp Immunol 1993;92:93-99.
20. Ho HN, Hultin LW, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce, Chou C-C, O'Rourke S, Taylor JMG, and Giorgi JV: Circulating HIV-specific CD8+ cytotoxic cells express CD38 and HLA-DR antigens. J Immunol 1993;150:3070-3079.
21. Brinchmann JE, Doblong TH, Heger BH, Haabeim LL, Sannes M, and Egeland T: Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: Functional and clinical correlations. J Infect Dis 1997;169:730-738.
22. Pitt J, Brambilla D, Reichelderfer P, Landay A, McIntosh K, Burns D, Hillyer GV, Mendez H, and Fowler MG for the Women and Infants Transmission Study: Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: Findings from the Women and Infants Transmission Study. J Infect Dis 1997;175:567-575.
23. Formby B: Immunologic response in pregnancy. Endocrinol Metab Clin N Am 1995;24:187-205.
24. Beer AE and Kwak YH: Immunology of normal pregnancy. In: Immunology and Allergy Clinics of North America: HIV and Women and Pregnancy (Shearer WT and Mofenson L, eds.), Vol. 18. W. B. Saunders, Philadelphia, 1998, pp. 249-270.
25. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-482.
26. Wasik TJ, Jagodzinski PP, Hyjek EM, Wustner J, Trinchieri G, Lischner HW, and Kozbor D: Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HTV infection. J Immunol 1997;158:6029-6036.
27. Bouscarat F, Levacher-Clergeot M, Dazza M-C, Strauss KW, Girard P-M, Ruggri C, and Sinet M: Correlation of CDS lymphocyte activation with cellular viremia and plasma HIV-RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1996; 12:17-24.
28. Pollack H, Zhan M-X, Safrit JT, Chen S-H, Rochford G, Tao P-Z, Koup R, Krasinski K, and Borkowsky W: CD8+ T cell mediated suppression of HIV replication in the first year of life: Association with lower viral load and favorable early survival. AIDS 1997; 11:F9-F13.
29. Mofenson L: Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994;5:252-265.
30. Plaeger-Marshall S, Hausner MA, Isacescu V, and Giorgi J: T cell mediated inhibition of HIV replication in HIV infected adults and children. AIDS Res Hum Retroviruses 1992;8:1375-1376.